Template:Fibromuscular dysplasia: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''F...") |
No edit summary |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 29: | Line 29: | ||
! | ! | ||
[[Fibromuscular dysplasia historical perspective|Historical Perspective]] | [[Fibromuscular dysplasia historical perspective|Historical Perspective]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Fibromuscular dysplasia classification|Classification]] | |||
|- | |- | ||
! | ! | ||
| Line 59: | Line 65: | ||
! | ! | ||
[[Fibromuscular dysplasia risk factors|Risk Factors]] | [[Fibromuscular dysplasia risk factors|Risk Factors]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Fibromuscular dysplasia screening|Screening]] | |||
|- | |- | ||
! | ! | ||
| Line 71: | Line 83: | ||
! | ! | ||
Diagnosis | Diagnosis | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Fibromuscular dysplasia diagnostic study of choice|Diagnostic Study of Choice]] | |||
|- | |- | ||
! | ! | ||
| Line 89: | Line 107: | ||
! | ! | ||
[[Fibromuscular dysplasia laboratory findings|Laboratory Findings]] | [[Fibromuscular dysplasia laboratory findings|Laboratory Findings]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Fibromuscular dysplasia electrocardiogram|Electrocardiorgram]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Fibromuscular dysplasia x ray|X-ray]] | |||
|- | |- | ||
! | ! | ||
| Line 106: | Line 136: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Fibromuscular dysplasia arteriography|Arteriography]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Fibromuscular dysplasia echocardiography or ultrasound|Echocardiography or Ultrasound]] | |||
|- | |- | ||
! | ! | ||
| Line 125: | Line 161: | ||
! | ! | ||
Treatment | Treatment | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Fibromuscular dysplasia management guidelines|Management Guidelines]] | |||
|- | |- | ||
! | ! | ||
| Line 164: | Line 206: | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
ASA/ACCF/AHA Guideline Recommendations | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Patients With Fibromuscular Dysplasia|Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries]] | |||
|- | |||
! | |||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Latest revision as of 12:57, 25 April 2018
|
Fibromuscular dysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ASA/ACCF/AHA Guideline Recommendations |
|
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
|
Case Studies |
|
Fibromuscular dysplasia On the Web |
|
American Roentgen Ray Society Images of Fibromuscular dysplasia |
|
Risk calculators and risk factors for Fibromuscular dysplasia |